Inactive Instrument

Company MRI Interventions Inc OTC Bulletin Board

Equities

MRIC

US55347P1003

Advanced Medical Equipment & Technology

Business Summary

ClearPoint Neuro, Inc. is a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. The Company’s flagship product is the ClearPoint Neuro Navigation System. Its initial product offering, the ClearPoint system, is an integrated system comprised of capital equipment and disposable products, designed to allow minimally invasive procedures in the brain to be performed in a magnetic resonance imaging (MRI) suite. The ClearPoint Array Neuro Navigation System and its principal disposable component is designed to be deployed in an operating room setting while also being usable in an MRI suite. It is engaged with healthcare and research centers in North America, Europe, Asia, and South America. It also provides solutions for direct CNS delivery of therapeutics in pre-clinical studies and clinical trials worldwide.

Sales per Business

USD in Million2022Weight2023Weight Delta
Biologics and Drug Delivery - Services and License
47.8 %
5 26.4 % 11 47.8 % +110.83%
Functional Neurosurgery Navigation and Therapy - Disposable Products
31.7 %
8 36.9 % 8 31.7 % +0.03%
Biologics and Drug Delivery - Disposable Products
9.0 %
4 18.0 % 2 9.0 % -41.63%
Capital Equipment and Software - Services
4.1 %
1 3.9 % 1 4.1 % +22.39%
Functional Neurosurgery Navigation and Therapy - Services
3.9 %
2 7.5 % 1 3.9 % -39.43%
Capital Equipment and Software - Systems and Software Products
3.6 %
2 7.4 % 1 3.6 % -43.12%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
21 100.0 % 24 100.0 % +16.56%

Managers

Managers TitleAgeSince
Chief Executive Officer 47 17-11-06
Director of Finance/CFO 39 20-09-28
Chief Operating Officer 44 22-10-09
Investor Relations Contact - -
Corporate Officer/Principal 41 20-06-30
General Counsel - 21-04-04
Sales & Marketing - 19-10-31
General Counsel - -
Sales & Marketing 58 12-11-11
Corporate Officer/Principal - 11-12-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 72 19-08-31
Director/Board Member 64 21-07-14
Chairman 78 17-05-08
Director/Board Member 64 14-09-02
Director/Board Member 66 14-03-09
Chief Executive Officer 47 17-11-06
Director/Board Member 52 20-04-15
Director/Board Member 57 21-11-01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 27,069,568 25,012,797 ( 92.40 %) 0 92.40 %

Shareholders

NameEquities%Valuation
1,794,948 6.654 % 12 M $
BlackRock Advisors LLC
5.239 %
1,413,193 5.239 % 10 M $
Vanguard Fiduciary Trust Co.
4.851 %
1,308,694 4.851 % 9 M $
894,578 3.316 % 6 M $
Geode Capital Management LLC
1.813 %
489,155 1.813 % 3 M $
Taylor Frigon Capital Management LLC
1.572 %
424,097 1.572 % 3 M $
348,898 1.293 % 2 M $
Brown Investment Advisory & Trust Co.
1.236 %
333,395 1.236 % 2 M $
263,364 0.9763 % 2 M $
Cahill Wealth Management LLC
0.8610 %
232,263 0.8610 % 2 M $

Company contact information

Clearpoint Neuro, Inc.

120 South Sierra Avenue Suite 100

92075, Solana Beach

+

http://www.clearpointneuro.com
address MRI Interventions Inc(MRIC)
  1. Stock Market
  2. Equities
  3. CLPT Stock
  4. MRIC Stock
  5. Company MRI Interventions Inc